Bicarbon valve - European multicenter clinical evaluation
نویسندگان
چکیده
منابع مشابه
Bicarbon valve -- European multicenter clinical evaluation.
OBJECTIVE Fifteen collaborating centers in eight countries present their pooled experience with the new Bicarbon bileaflet valve. METHODS Between 4/90 and 4/96, 1351 patients, 806 males and 545 females, aged 10 to 83, mean 58.4 +/- 12.4, underwent valve implantation. OPERATIONS aortic valve replacement (AVR), 726; mitral valve replacement (MVR), 475; double valve replacement (DVR), 150. Add...
متن کاملClinical experience with the Bicarbon heart valve prosthesis
BACKGROUND We have previously reported mid-term results of a study, which ended in January 2000, on the Bicarbon valve. The study concluded that the valve showed excellent clinical results, associated with a low incidence of valve-related complications. In the present study, the same patients were prospectively followed for an additional 5 years. METHODS Forty-four patients had aortic valve r...
متن کاملFifteen-year experience with the Bicarbon heart valve prosthesis in a single center
BACKGROUND The purpose of this study was to evaluate retrospectively the clinical performance of the Bicarbon valve (Sorin Biomedica Cardio, Saluggia, Italy) implanted at our center in Japan. METHODS Between January 1997 and December 2011, 415 patients in our institution were implanted with the Bicarbon valve. Nine of these recipients were excluded from the study because they had already unde...
متن کاملMulticenter Clinical Evaluation of BacT/Alert Virtuo Blood Culture System
BacT/Alert Virtuo is an advanced, automated blood culture system incorporating improved automation and an enhanced detection algorithm to shorten time to detection. A multicenter study of the investigational Virtuo system (bioMérieux, Inc., Durham, NC) compared to BacT/Alert 3D (BTA3D) for detection of bacteremia/fungemia in four bottle types, SA and FA Plus (aerobic) and SN and FN Plus (anaero...
متن کاملA multicenter clinical evaluation of the Clot Signature Analyzer.
BACKGROUND The Clot Signature Analyzer (CSA) was designed to assess global hemostasis as a screening assay using non-anticoagulated whole blood. Three different measurements are produced by the instrument: platelet hemostasis time (PHT), clot time (CT), and collagen-induced thrombus formation (CITF). OBJECTIVES The purpose of the present study was to determine normal ranges for these measurem...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Journal of Cardio-Thoracic Surgery
سال: 1998
ISSN: 1873-734X,1010-7940
DOI: 10.1016/s1010-7940(98)00074-8